CIITA p.Pro211Ser
c.631C>T · rs201764329 · VCV1410833
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0793 | likely benign |
|---|---|---|
| REVEL | 0.071 | moderately benign-leaning |
| SaProt | LLR -6.38 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.88 | GERP -4.5 |
| Regional constraint | o/e 1.10 | unconstrained · MANE · 46 kb · p 6.2e-05 · regional, not allelic |
| Overall | ||
| CADD | 2.444 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.00833% | 12,006 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,628 |
| European (non-Finnish) | 0.00407% | 24,584 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CIITA
- Protein
- p.Pro211Ser
- Coding
- c.631C>T
- MANE Select
- NM_000246
- dbSNP
- rs201764329
- Type
- single nucleotide variant
- Location
- chr16:10902660 (GRCh38)
- Gene constraint
- LOEUF 0.729 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 69.10
Disease context
MHC class II deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: rheumatoid arthritis
For Immunodeficiency by defective expression of MHC class II (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- CIITA p.Pro211His Uncertain significance ★ ⚠ same residue
- CIITA p.Pro211= Likely benign ★ same residue
- CIITA p.Pro211fs Pathogenic/Likely pathogenic ★★ same residue
- CIITA c.199+1G>A Likely pathogenic ★★ same condition
- CIITA c.2888+1G>A Pathogenic/Likely pathogenic ★★ same condition
- CIITA c.2889-1G>T Pathogenic/Likely pathogenic ★★ same condition
- CIITA c.436+1G>A Likely pathogenic ★★ same condition
- CIITA c.628+1G>A Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ciita-p-pro211ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown